
    
      Vildagliptin (50 mg BID) or placebo is given as add-on to insulin treatment for four weeks in
      patients with type 1 diabetes. Then, a hypoglycemic clamp (2.5 mmol/l glucose) is undertaken
      with the determination of glucagon.
    
  